AM-IA brings together news, research papers and applications relating to artificial intelligence published around the world into a single feed — and makes them available in your European language at the click of a button.
Scroll to browse · Click to filter
AI Highlights, CapsoVision's tool, tracks suspicious images in CapsoCam Plus recordings and takes them back to the doctor first.
According to the Blue Cross Blue Shield Association, the AI tools used by hospitals are documenting more "complex" patients without changing the care provided.
The Blue Cross Blue Shield association blames this deviation on secondary diagnoses charged more often, without corresponding treatment. Hospitals dispute this reading.
Out of 22,349 stays, a tool integrated into the patient file equals case managers on the first day, but is twice as wrong as them 24 hours before discharge.
Already deployed in more than 75 medical centers, the Clinical Documentation Assistant provides access to the largest integrated care network in the United States.
In a multicenter randomized trial published by Nature Medicine, a model that predicts 17 categories of genotypes from retinal images saves ophthalmologists twenty points.
A network with $4.4 million over three years is intended to give small institutions access to the evaluation grids and audits available to large hospital systems.
The clinical search engine has gone from $12 billion to $15 billion in valuation in eight months, and has announced a first candidate in clinical trials before the end of the year.
After three years of negotiations without an agreement, the practitioners of two Allina Health hospitals are demanding a right to review the place of algorithms in care and billing.
Trained on X-rays of U.S. workers, Michigan State's tool supports the 200 certified specialists still practicing across the country.
Anthropic announces that a 21:30 autonomous agent campaign isolated a trio of reverse transcriptase + partner gene + network of regular repetitions evoking a CRISPR locus.
In the spring of 2027, five new pathologies will join the system that remunerates technology providers on the results obtained in patients, and not on the volume of procedures.
Powerful Medical's algorithm targets complete coronary occlusions that are not obvious from the tracing, in order to refer patients to a cath room faster.
Published in Nature Biotechnology, the AIntibody challenge put 29 organizations in competition on criteria measured in the benchtop. The best variants gain up to 75 times in affinity.
Faced with calls from OpenAI and Anthropic to temper the race to the border, the head of drug discovery at the Alphabet subsidiary believes that his work does not depend on it.
Alibaba's Damo lab has released an open-source model that reads injected abdominal scans and covers 18 organs, with an average AUC of 0.913 across 146 clinical signs.
Published in Nature Biotechnology, the analysis of a phase IIa trial applies several aging clocks in parallel to a drug intervention for the first time.
More than a thousand pages obtained by the Electronic Frontier Foundation document the rushed launch of the WISeR model, and the subsequent delays in care in six states.
Researchers at Stanford ran a pharmaceutical company entirely populated by software agents. The cancer treatment she designed was then found, identically, by a real laboratory.
Models trained in Sweden, Chile and Singapore are ahead of current evaluation methods — but none work as well in all three countries.